⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9213569 | 1.00 | — | — | |
| SCHEMBL9206261 | 1.00 | — | — | |
| SCHEMBL4335883 | 1.00 | — | — | |
| SCHEMBL9214170 | 1.00 | — | — | |
| SCHEMBL4338677 | 0.98 | — | — | |
| SCHEMBL9211856 | 0.98 | — | — | |
| SCHEMBL9209394 | 0.98 | — | — | |
| SCHEMBL3940048 | 0.98 | — | — | |
| SCHEMBL9211916 | 0.98 | — | — | |
| SCHEMBL9208887 | 0.98 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0421441-B1 | Pantothenic acid derivatives | FUJIREBIO KK (JP) | 1995-01-25 | — | — | EP | disclosed |
| US-5120738-A | Cardiovascular disorders | FUJIREBIO INC. (JP) | 1992-06-09 | — | — | US | disclosed |